Arrays and methods of use
View Patent ↗Methods are provided for producing a molecular array comprising a plurality of molecules immobilized to a solid substrate at a density which allows individual immobilized molecules to be individually resolved, wherein each individual molecule in the array is spatially addressable and the identity of each molecule is known or determined prior to immobilization. The use of spatially addressable low density molecular arrays in single molecule detection and analysis techniques is also provided. Novel assays and methods are also provided.
1. A method of producing a molecular array comprising:
(i) preselecting a plurality of oligonucleotides to be immobilised;
(ii) labeling at least a portion of the plurality of oligonucleotides with one or more labels, thereby producing labeled oligonucleotides;
(iii) immobilising at least a portion of the labeled oligonucleotides on a solid support at a density to allow each of said at least a portion of the labeled oligonucleotides on the solid support to be individually resolved, thereby forming two or more separate and discrete elements, at least two elements of said two or more elements being spatially addressable, each of said at least two elements comprising a plurality of labeled immobilised oligonucleotides from said at least a portion of the labeled oligonucleotides,
wherein sequence identities of said at least a portion of the plurality of labeled immobilised oligonucleotides in each of said at least two elements is specified by a location of each of said at least two elements in which the oligonucleotides are contained; and
(iv) analysing whether at least a portion of the labeled immobilised oligonucleotides of said at least two elements is individually optically resolvable from another portion of the labeled immobilised oligonucleotides, whereby said at least a portion of the labeled immobilised oligonucleotides on each of said at least two elements is individually optically resolvable from the another portion of the labeled immobilised oligonucleotides.
2. The method according to claim 1 , wherein the one or more labels can be detected by optical methods.
3. The method according to claim 2 , wherein the one or more labels is selected from the group consisting of a single optically active dye and fluorescent molecule, and a plurality of optically active dyes and fluorescent molecules.
4. The method according to claim 1 , wherein the oligonucleotides are cDNA and/or genomic DNA.
5. The method according to claim 1 , wherein the immobilising step comprises applying the labeled oligonucleotides to the solid support by a method selected from the group consisting of printing, electronic addressing, in situ light-directed synthesis, ink jet synthesis, physical masking, and spotting.
6. The method according to claim 1 , wherein the plurality of oligonucleotides are identical oligonucleotides.
7. The method according to claim 1 , wherein the plurality of oligonucleotides include functional molecules with different identities.
8. The method according to claim 1 , wherein the immobilising step comprises centrifuging the labeled oligonucleotides on the solid support.
9. The method according to claim 1 , wherein the solid support comprises a material selected from the group consisting of glass, quartz, silicon wafers, mica, ceramics organic polymers, plastics, polystyrene and polymethacrylate.
10. The method according to claim 1 , wherein the labeled immobilised oligonucleotides are separated by a distance of approximately at least 250 nm.
11. The method according to claim 1 , wherein the labeled immobilised oligonucleotides are separated by a distance of approximately at least 800 nm.
12. The method according to claim 1 , wherein the labeled immobilised oligonucleotides are separated by a distance from 250 to 800 nm.
13. The method according to claim 1 , wherein one of the at least two elements is adjacent to another element.
14. The method according to claim 1 , wherein each of the at least two elements is from 1 μm to 300 μm apart.
15. The method according to claim 1 , wherein each of the at least two elements has a dimension from 150 μm to 300 μm.
16. The method according to claim 1 , wherein each of the at least two elements has a dimension larger than 500 μm.
17. The method according to claim 1 , wherein the oligonucleotides have a length from 13 to 25 nucleotides.
18. The method according to claim 1 , wherein the oligonucleotides have a length longer than 25 nucleotides.
19. The method according to claim 1 , wherein the at least two elements are separated by a raised region or an etched trench.
20. The method according to claim 1 , wherein the one or more labels are fluorescent labels.
21. The method according to claim 1 , further comprising counting the number of the labeled immobilised oligonucleotides in each element of the at least two elements.
22. The method according to claim 21 , wherein the labeled immobilised oligonucleotides within each element of the at least two elements are counted for one or more diagnostic purposes.
23. The method according to claim 1 , wherein the labeling is performed by hybridising a labeled probe to only a portion of the plurality of oligonucleotides.
24. The method of claim 23 , wherein the labeled probe is a labeled oligonucleotide.
25. The method according to claim 1 , wherein the one or more labels are two or more different labels.
26. The method according to claim 1 , wherein the solid support is a microtiter plate comprising raised region separating the two or more separate and discrete elements.
27. The method according to claim 1 , wherein said at least a portion of the labeled immobilised oligonucleotides comprises circularized DNA.
28. The method according to claim 1 , wherein at least a portion of the plurality of oligonucleotides is amplified by rolling circle amplification.
29. The method according to claim 1 , wherein
said plurality of labeled immobilized oligonucleotides comprise first immobilising means selected from the group consisting of (i) biotins, (ii) sulfhydryl (SH) groups, (iii) amine groups, (iv) phenylboronic acid (PBA) groups, and (v) acrydite groups, and
said solid support comprises second immobilising means selected from the group consisting of (i) avidin, strepatavidin, or neutravidin, (ii) SH groups, (iii) activated carboxylate or aldehyde groups, (iv) salicylhydroxamic acid (SHA) groups, and (v)thiol surface, silane surface, or the surface containing acrylamide monomers.
30. A method of performing an assay comprising: producing the molecular array according to the method of claim 1 , and performing the assay comprising counting a total number of at least a part of the plurality of labeled immobilised oligonucleotides of said at least two elements.